Neurescue Revenue and Competitors
Estimated Revenue & Valuation
- Neurescue's estimated annual revenue is currently $5M per year.
- Neurescue's estimated revenue per employee is $251,000
Employee Data
- Neurescue has 20 Employees.
- Neurescue grew their employee count by -5% last year.
Neurescue's People
Name | Title | Email/Phone |
---|---|---|
1 | Founder & CEO | Reveal Email/Phone |
2 | Senior Clinical & Scientific Affairs Director | Reveal Email/Phone |
3 | Senior Clinical & Scientific Affairs Manager | Reveal Email/Phone |
Neurescue Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is Neurescue?
Neurescue, a medical device manufacturer based in Denmark, is developing cardiovascular devices to help emergency patients. Our first product, the NEURESCUE device, is the first computer-aided aortic occlusion catheter. This procedure redirects blood flow to the central circulation. Our future goal is to enable the clinical utility of further intelligent procedures.
keywords:N/AN/A
Total Funding
20
Number of Employees
$5M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Neurescue News
2022-04-13 - Balloon Catheters Market Contemplated to Witness a Tremendous CAGR of 8.78%
by 2026, As per DelveInsight
In June 2021, Neurescue received the 510k clearance from the US Food and Drug Administration for their NEURESCUE® device, 'the world's first...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2M | 20 | 33% | N/A |
#2 | $3.5M | 20 | -9% | N/A |
#3 | $2.4M | 20 | 5% | N/A |
#4 | $2.1M | 21 | N/A | N/A |
#5 | $2.1M | 21 | N/A | N/A |